BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND NFKBIE, ENSG00000146232, 4794, O00221, IKBE
12 results:

  • 1. Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma.
    Ma G; Gao Y; Jing X; He C; Liu H; Wu X; Gao Z; Li Y; Zhang S; Zhao G
    Leuk Lymphoma; 2023 Jan; 64(1):140-150. PubMed ID: 36215154
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Histiocytic Sarcoma With CCND1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell lymphoma.
    Kumar J; Al-Kawaaz M; Martin BA; Hegazi MM; Tan B; Gratzinger D
    Am J Clin Pathol; 2022 Oct; 158(4):449-455. PubMed ID: 35964234
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutational landscape of gray zone lymphoma.
    Sarkozy C; Hung SS; Chavez EA; Duns G; Takata K; Chong LC; Aoki T; Jiang A; Miyata-Takata T; Telenius A; Slack GW; Molina TJ; Ben-Neriah S; Farinha P; Dartigues P; Damotte D; Mottok A; Salles GA; Casasnovas RO; Savage KJ; Laurent C; Scott DW; Traverse-Glehen A; Steidl C
    Blood; 2021 Apr; 137(13):1765-1776. PubMed ID: 32961552
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study.
    Camus V; Viennot M; Lequesne J; Viailly PJ; Bohers E; Bessi L; Marcq B; Etancelin P; Dubois S; Picquenot JM; Veresezan EL; Cornic M; Burel L; Loret J; Becker S; Decazes P; Lenain P; Lepretre S; Lemasle E; Lanic H; Ménard AL; Contentin N; Tilly H; Stamatoullas A; Jardin F
    Haematologica; 2021 Jan; 106(1):154-162. PubMed ID: 32079702
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
    Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
    Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell lymphoma, Leg Type during Ibrutinib Therapy.
    Fox LC; Yannakou CK; Ryland G; Lade S; Dickinson M; Campbell BA; Prince HM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899297
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell lymphoma, Leg Type.
    Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
    J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients.
    Arvidsson G; Henriksson J; Sander B; Wright AP
    Haematologica; 2018 Apr; 103(4):666-678. PubMed ID: 29449436
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Frequent nfkbie deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.
    Mansouri L; Noerenberg D; Young E; Mylonas E; Abdulla M; Frick M; Asmar F; Ljungström V; Schneider M; Yoshida K; Skaftason A; Pandzic T; Gonzalez B; Tasidou A; Waldhueter N; Rivas-Delgado A; Angelopoulou M; Ziepert M; Arends CM; Couronné L; Lenze D; Baldus CD; Bastard C; Okosun J; Fitzgibbon J; Dörken B; Drexler HG; Roos-Weil D; Schmitt CA; Munch-Petersen HD; Zenz T; Hansmann ML; Strefford JC; Enblad G; Bernard OA; Ralfkiaer E; Erlanson M; Korkolopoulou P; Hultdin M; Papadaki T; Grønbæk K; Lopez-Guillermo A; Ogawa S; Küppers R; Stamatopoulos K; Stavroyianni N; Kanellis G; Rosenwald A; Campo E; Amini RM; Ott G; Vassilakopoulos TP; Hummel M; Rosenquist R; Damm F
    Blood; 2016 Dec; 128(23):2666-2670. PubMed ID: 27670424
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
    Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
    Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell lymphomas.
    Morin RD; Assouline S; Alcaide M; Mohajeri A; Johnston RL; Chong L; Grewal J; Yu S; Fornika D; Bushell K; Nielsen TH; Petrogiannis-Haliotis T; Crump M; Tosikyan A; Grande BM; MacDonald D; Rousseau C; Bayat M; Sesques P; Froment R; Albuquerque M; Monczak Y; Oros KK; Greenwood C; Riazalhosseini Y; Arseneault M; Camlioglu E; Constantin A; Pan-Hammarstrom Q; Peng R; Mann KK; Johnson NA
    Clin Cancer Res; 2016 May; 22(9):2290-300. PubMed ID: 26647218
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.
    Mansouri L; Sutton LA; Ljungström V; Bondza S; Arngården L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Plevova K; Young E; Gunnarsson R; Falk-Sörqvist E; Lönn P; Muggen AF; Yan XJ; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Rung J; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellström M; Jernberg-Wiklund H; Ghia P; Söderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
    J Exp Med; 2015 Jun; 212(6):833-43. PubMed ID: 25987724
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.